Neoplasms, Colorectal Completed Phase 1 Trials for Cetuximab (DB00002)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

DBCOND0036298 (Neoplasms, Colorectal)Completed1 IdentifierTitlePurposeDrugs
NCT00540943Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal CancerTreatment
NCT00478634A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal CancerTreatment